How have AQS shares performed in 2024?

Aequus Pharmaceuticals' stock was trading at C$0.03 at the start of the year. Since then, AQS stock has decreased by 40.0% and is now trading at C$0.02. View the best growth stocks for 2024 here .

When is Aequus Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 4th 2024. View our AQS earnings forecast .

What other stocks do shareholders of Aequus Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aequus Pharmaceuticals investors own include GrowLife (PHOT) , Unrivaled Brands (TRTC) , Abbott Laboratories (ABT) , Acorn Energy (ACFN) , Crown Castle (CCI) , Charlotte's Web (CWBHF) , (FIRE.V) (FIRE) , LiCo Energy Metals (LIC) , Marijuana Company of America (MCOA) and Planet 13 (PLNHF) .

How do I buy shares of Aequus Pharmaceuticals?

Shares of AQS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

CVE:AQS

Aequus Pharmaceuticals (AQS) Stock Price, News & Analysis

→ This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad)

Free AQS Stock Alerts

C$0.02

-0.01 (-25.00%)

(As of 04/17/2024 05:33 PM ET)

Compare

Today's Range: C$0.02
▼
C$0.02
50-Day Range: C$0.01
▼
C$0.02
52-Week Range: C$0.01
▼
C$0.06

Volume: 15,000 shs
Average Volume: 124,794 shs
Market Capitalization: C$1.99 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Earnings Headlines Insider Trades

Get Aequus Pharmaceuticals alerts:

Ad Darwin

Your Next Portfolio Star: Revealing 2024's Top Stock Pick

We're thrilled to offer you an exclusive look at the #1 Buy & Hold Stock of 2024. This isn't just any report. It's the culmination of rigorous analysis, expert insights, and cutting-edge financial strategies, distilled into a compelling narrative that charts the course of what we believe to be the year's most promising investment. (**By clicking the link you are subscribing to The Wealth Creation Investing Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)

Click here to download your report

About Aequus Pharmaceuticals Stock (CVE:AQS)

Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.

AQS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

AQS Stock News Headlines

April 10, 2024 | americanbankingnews.com

Aequus Pharmaceuticals (CVE:AQS) Shares Up 33.3%

February 23, 2024 | theglobeandmail.com

Zoomd Technologies: Top 10 Undervalued Growth Stocks on TSX-V (ZOMD)

April 18, 2024 | DTI (Ad)

With the “Bitcoin Loophole” you can supercharge the gains by 10x or more

Thanks to this newly discovered Bitcoin Loophole, you can now trade Bitcoin in any regular brokerage account… And not only that… you can use it to supercharge the gains of Bitcoin by 10x or more! You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history. That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords…

February 18, 2024 | theglobeandmail.com

Aequus Pharmaceuticals: Top 10 Undervalued Drug Manufacturers Industry Stocks (AQS)

December 12, 2023 | morningstar.com

Aequus Pharmaceuticals Inc AQS

November 30, 2023 | msn.com

Aequus Pharmaceuticals reports Q3 results

October 18, 2023 | theglobeandmail.com

Closing Bell: Aequus Pharmaceuticals Inc up on Thursday (AQS)

October 7, 2023 | theglobeandmail.com

Closing Bell: Aequus Pharmaceuticals Inc flat on Thursday (AQS)

April 18, 2024 | DTI (Ad)

With the “Bitcoin Loophole” you can supercharge the gains by 10x or more

October 5, 2023 | theglobeandmail.com

Closing Bell: Aequus Pharmaceuticals Inc flat on Tuesday (AQS)

September 29, 2023 | theglobeandmail.com

Closing Bell: Aequus Pharmaceuticals Inc flat on Friday (AQS)

September 29, 2023 | theglobeandmail.com

Closing Bell: Aequus Pharmaceuticals Inc flat on Wednesday (AQS)

August 30, 2023 | finanznachrichten.de

Aequus Pharmaceuticals: Aequus Reports Second Quarter 2023 Financial Highlights and General Update

August 29, 2023 | markets.businessinsider.com

Aequus Reports Second Quarter 2023 Financial Highlights and General Update

August 25, 2023 | theglobeandmail.com

Closing Bell: Aequus Pharmaceuticals Inc up on Wednesday (AQS)

August 24, 2023 | finance.yahoo.com

Aequus Announces Zimed PF Now Available in Canada

August 22, 2023 | finance.yahoo.com

Aequus Announces Zimed PF Website Launch

August 18, 2023 | finance.yahoo.com

Aequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in Canada

July 6, 2023 | benzinga.com

Aequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%)

June 7, 2023 | ca.finance.yahoo.com

AQS.V - Aequus Pharmaceuticals Inc.

May 31, 2023 | finanznachrichten.de

Aequus Pharmaceuticals: Aequus Provides General Update and First Quarter 2023 Financial Highlights

May 31, 2023 | finance.yahoo.com

Aequus Provides General Update and First Quarter 2023 Financial Highlights

May 2, 2023 | finance.yahoo.com

Aequus Provides General Update and Fiscal 2022 Financial Results

April 19, 2023 | finance.yahoo.com

Aequus Grants Stock Options

April 5, 2023 | finance.yahoo.com

Aequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%) and Board Update

March 26, 2023 | finance.yahoo.com

Aequus Pharmaceuticals Inc. (AQS.V)

December 20, 2022 | finance.yahoo.com

Aequus Announces Health Canada Notice of Compliance (NOC) for Zimed® Preservative Free (Bimatoprost 0.03%)

See More Headlines

Receive AQS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aequus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/17/2024
Next Earnings (Estimated): 6/04/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: CVE
Sector: Medical
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Current Symbol: CVE:AQS
CUSIP: N/A
CIK: N/A
Web: www.aequuspharma.ca
Phone: +1-604-3367906
Fax: N/A
Employees: 12
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): C($0.02)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: C$-3,270,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -1,569.60%
Return on Assets: -83.91%

Debt

Debt-to-Equity Ratio: 138.88
Current Ratio: 0.12
Quick Ratio: 0.46

Sales & Book Value

Annual Sales: C$1.17 million
Price / Sales: 1.70
Cash Flow: C$0.00 per share
Price / Cash Flow: 5.00
Book Value: C($0.03) per share
Price / Book: -0.50

Miscellaneous

Outstanding Shares: 132,630,000
Free Float: N/A
Market Cap: C$1.99 million
Optionable: Not Optionable
Beta: 0.37

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Mr. Douglas Glen Janzen (Age 55)
Chairman, CEO & President
Comp: $206.25k
Ms. Ann Fehr CGA (Age 55)
CPA, CFO & Corporate Secretary
Comp: $136.13k
Mr. Grant Larsen
Chief Commercial Officer

Key Competitors

View All Competitors

AQS Stock Analysis - Frequently Asked Questions

How have AQS shares performed in 2024?: Aequus Pharmaceuticals' stock was trading at C$0.03 at the start of the year. Since then, AQS stock has decreased by 40.0% and is now trading at C$0.02.
View the best growth stocks for 2024 here.
When is Aequus Pharmaceuticals' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 4th 2024.
View our AQS earnings forecast.
What other stocks do shareholders of Aequus Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Aequus Pharmaceuticals investors own include GrowLife (PHOT), Unrivaled Brands (TRTC), Abbott Laboratories (ABT), Acorn Energy (ACFN), Crown Castle (CCI), Charlotte's Web (CWBHF), (FIRE.V) (FIRE), LiCo Energy Metals (LIC), Marijuana Company of America (MCOA) and Planet 13 (PLNHF).
How do I buy shares of Aequus Pharmaceuticals?: Shares of AQS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:AQS) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial